Spots Global Cancer Trial Database for A Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCC
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCC
Official Title: A Translational Study of Tumor Antigen-pulsed Dendritic Cell Vaccine for Esophageal Squamous Cell Carcinoma
Study ID: NCT05317325
Conditions
Interventions
Study Description
Brief Summary: The aim of this single center, single arm and prospective study is to explore the safety and efficacy of tumor antigen-pulsed DC vaccine( OCDC and NeoDC) for postoperative adjuvant treatment of ESCC
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
West China Hospital, Chengdu, Sichuan, China
Contact Details
Name: Zhen-Yu Ding, Prof
Affiliation: Sichuan University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
